| - GRCh37:
- Chr1:156084700-156085075
- GRCh38:
- Chr1:156114909-156115284
| LMNA | | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jan 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084710
- GRCh38:
- Chr1:156114919
| LMNA | M1L | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084710-156085065
- GRCh38:
- Chr1:156114919-156115274
| LMNA | | Primary dilated cardiomyopathy, Laminopathy | Pathogenic (Nov 25, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084712
- GRCh38:
- Chr1:156114921
| LMNA | M1I | Charcot-Marie-Tooth disease type 2, not provided, See cases
| Pathogenic (Feb 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084712
- GRCh38:
- Chr1:156114921
| LMNA | M1I | not provided | Pathogenic (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084712
- GRCh38:
- Chr1:156114921
| LMNA | M1I | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic/Likely pathogenic (Apr 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084713
- GRCh38:
- Chr1:156114922
| LMNA | E2* | Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype | Pathogenic (Nov 29, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084716-156084717
- GRCh38:
- Chr1:156114925-156114926
| LMNA | S5fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084720
- GRCh38:
- Chr1:156114929
| LMNA | P4Q | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084720
- GRCh38:
- Chr1:156114929
| LMNA | P4R | Charcot-Marie-Tooth disease type 2 | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084722
- GRCh38:
- Chr1:156114931
| LMNA | S5fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084723
- GRCh38:
- Chr1:156114932
| LMNA | Q6fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084725
- GRCh38:
- Chr1:156114934
| LMNA | Q6* | Primary dilated cardiomyopathy | Pathogenic (Jun 2, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084737
- GRCh38:
- Chr1:156114946
| LMNA | T10P | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084738
- GRCh38:
- Chr1:156114947
| LMNA | T10I | Inborn genetic diseases, not provided, Familial partial lipodystrophy, Dunnigan type
| Pathogenic/Likely pathogenic (Mar 15, 2016) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084752
- GRCh38:
- Chr1:156114961
| LMNA | Q15* | Charcot-Marie-Tooth disease type 2 | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084756
- GRCh38:
- Chr1:156114965
| LMNA | S17fs | not provided | Pathogenic (Jan 20, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084759-156084760
- GRCh38:
- Chr1:156114968-156114969
| LMNA | T19fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084768
- GRCh38:
- Chr1:156114977
| LMNA | P20L | Congenital muscular dystrophy due to LMNA mutation | Likely pathogenic (Dec 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084773
- GRCh38:
- Chr1:156114982
| LMNA | S22A | not provided | Likely pathogenic (Feb 20, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084774
- GRCh38:
- Chr1:156114983
| LMNA | S22fs | not provided | Pathogenic (Aug 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084774-156084775
- GRCh38:
- Chr1:156114983-156114984
| LMNA | S22fs | not provided | Pathogenic (Apr 29, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084780
- GRCh38:
- Chr1:156114989
| LMNA | R25fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jan 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084782
- GRCh38:
- Chr1:156114991
| LMNA | R25C | Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084782
- GRCh38:
- Chr1:156114991
| LMNA | R25G | Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2, not provided
| Pathogenic/Likely pathogenic (Jul 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084783
- GRCh38:
- Chr1:156114992
| LMNA | R25P | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084789
- GRCh38:
- Chr1:156114998
| LMNA | T27I | Dilated cardiomyopathy 1A, Congenital muscular dystrophy due to LMNA mutation | Likely pathogenic (Sep 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084791
- GRCh38:
- Chr1:156115000
| LMNA | R28G | Inborn genetic diseases | Likely pathogenic (Dec 28, 2012) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084791
- GRCh38:
- Chr1:156115000
| LMNA | R28W | Charcot-Marie-Tooth disease type 2 | Pathogenic (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084792
- GRCh38:
- Chr1:156115001
| LMNA | R28Q | not provided, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Charcot-Marie-Tooth disease type 2
| Pathogenic/Likely pathogenic (Sep 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084798-156084800
- GRCh38:
- Chr1:156115007-156115009
| LMNA | E31del | Charcot-Marie-Tooth disease type 2 | Pathogenic (Oct 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084800
- GRCh38:
- Chr1:156115009
| LMNA | E31K | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084801
- GRCh38:
- Chr1:156115010
| LMNA | E31G | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084801-156084803
- GRCh38:
- Chr1:156115010-156115012
| LMNA | K32del | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084803
- GRCh38:
- Chr1:156115012
| LMNA | K32* | Charcot-Marie-Tooth disease type 2 | Pathogenic (Apr 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084803
- GRCh38:
- Chr1:156115012
| LMNA | K32E | Congenital muscular dystrophy due to LMNA mutation, Charcot-Marie-Tooth disease type 2 | Pathogenic/Likely pathogenic (Sep 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084807
- GRCh38:
- Chr1:156115016
| LMNA | E33G | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084808
- GRCh38:
- Chr1:156115017
| LMNA | E33D | not provided | Likely pathogenic (Aug 24, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084821
- GRCh38:
- Chr1:156115030
| LMNA | L38V | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084824
- GRCh38:
- Chr1:156115033
| LMNA | N39D | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084824
- GRCh38:
- Chr1:156115033
| LMNA | N39H | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084825
- GRCh38:
- Chr1:156115034
| LMNA | N39I | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084825
- GRCh38:
- Chr1:156115034
| LMNA | N39S | Charcot-Marie-Tooth disease type 2, not provided, Benign scapuloperoneal muscular dystrophy with cardiomyopathy
| Pathogenic (Dec 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084826
- GRCh38:
- Chr1:156115035
| LMNA | N39K | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084831
- GRCh38:
- Chr1:156115040
| LMNA | R41P | not provided | Likely pathogenic (Jul 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084831
- GRCh38:
- Chr1:156115040
| LMNA | R41H | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic (Apr 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084834
- GRCh38:
- Chr1:156115043
| LMNA | L42S | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084837
- GRCh38:
- Chr1:156115046
| LMNA | A43E | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084844
- GRCh38:
- Chr1:156115053
| LMNA | Y45* | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084851
- GRCh38:
- Chr1:156115060
| LMNA | R48G | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084852
- GRCh38:
- Chr1:156115061
| LMNA | R48P | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084863
- GRCh38:
- Chr1:156115072
| LMNA | L52V | Primary dilated cardiomyopathy | Likely pathogenic (Aug 10, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084867
- GRCh38:
- Chr1:156115076
| LMNA | E53G | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic/Likely pathogenic (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084871-156084872
- GRCh38:
- Chr1:156115080-156115081
| LMNA | N56fs | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084872
- GRCh38:
- Chr1:156115081
| LMNA | E55* | Charcot-Marie-Tooth disease type 2 | Pathogenic (Sep 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084873
- GRCh38:
- Chr1:156115082
| LMNA | E55G | Hutchinson-Gilford syndrome | Likely pathogenic (Nov 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084873-156084877
- GRCh38:
- Chr1:156115082-156115086
| LMNA | E55fs | not provided | Likely pathogenic (Nov 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084877
- GRCh38:
- Chr1:156115086
| LMNA | N56K | Congenital muscular dystrophy due to LMNA mutation, Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, Dilated cardiomyopathy 1A, Familial partial lipodystrophy, Dunnigan type, Heart-hand syndrome, Slovenian type, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Hutchinson-Gilford syndrome | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084878
- GRCh38:
- Chr1:156115087
| LMNA | A57P | Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome | Pathogenic (Feb 15, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr1:156084885
- GRCh38:
- Chr1:156115094
| LMNA | L59R | Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome | Pathogenic (Feb 15, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr1:156084887
- GRCh38:
- Chr1:156115096
| LMNA | R60G | Familial partial lipodystrophy, Dunnigan type, Dilated cardiomyopathy 1A | Pathogenic (Aug 27, 2002) | no assertion criteria provided |
| - GRCh37:
- Chr1:156084888
- GRCh38:
- Chr1:156115097
| LMNA | R60P | not provided | Likely pathogenic (Dec 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084893
- GRCh38:
- Chr1:156115102
| LMNA | R62C | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084893
- GRCh38:
- Chr1:156115102
| LMNA | R62G | not provided, Cardiomyopathy, Charcot-Marie-Tooth disease type 2, Familial partial lipodystrophy, Dunnigan type | Pathogenic (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084894-156084895
- GRCh38:
- Chr1:156115103-156115104
| LMNA | I63fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Feb 24, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084894
- GRCh38:
- Chr1:156115103
| LMNA | R62L | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084902
- GRCh38:
- Chr1:156115111
| LMNA | E65K | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084903
- GRCh38:
- Chr1:156115112
| LMNA | E65V | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084903
- GRCh38:
- Chr1:156115112
| LMNA | E65G | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084912
- GRCh38:
- Chr1:156115121
| LMNA | E68V | Charcot-Marie-Tooth disease type 2 | Pathogenic (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084913
- GRCh38:
- Chr1:156115122
| LMNA | V69fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084919
- GRCh38:
- Chr1:156115128
| LMNA | S71fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jun 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084926
- GRCh38:
- Chr1:156115135
| LMNA | E73* | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic (Apr 13, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084943
- GRCh38:
- Chr1:156115152
| LMNA | K78N | Arrhythmogenic right ventricular dysplasia 9 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084946-156084963
- GRCh38:
- Chr1:156115155-156115172
| LMNA | | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084953
- GRCh38:
- Chr1:156115162
| LMNA | E82* | Cardiovascular phenotype | Pathogenic (Dec 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084953
- GRCh38:
- Chr1:156115162
| LMNA | E82K | Charcot-Marie-Tooth disease type 2, not provided, Primary dilated cardiomyopathy
| Pathogenic (Apr 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084954
- GRCh38:
- Chr1:156115163
| LMNA | E82G | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084956-156084957
- GRCh38:
- Chr1:156115165-156115166
| LMNA | E84fs | Charcot-Marie-Tooth disease type 2 | Pathogenic (Oct 8, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084959
- GRCh38:
- Chr1:156115168
| LMNA | E84* | Charcot-Marie-Tooth disease type 2 | Pathogenic (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084963
- GRCh38:
- Chr1:156115172
| LMNA | L85H | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084974
- GRCh38:
- Chr1:156115183
| LMNA | R89G | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084975
- GRCh38:
- Chr1:156115184
| LMNA | R89P | Charcot-Marie-Tooth disease type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084975
- GRCh38:
- Chr1:156115184
| LMNA | R89L | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084983
- GRCh38:
- Chr1:156115192
| LMNA | L92F | Primary familial dilated cardiomyopathy, Cardiovascular phenotype | Likely pathogenic (Apr 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156084984
- GRCh38:
- Chr1:156115193
| LMNA | L92P | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084989
- GRCh38:
- Chr1:156115198
| LMNA | S94P | Charcot-Marie-Tooth disease type 2 | Pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156084992-156084993
- GRCh38:
- Chr1:156115201-156115202
| LMNA | V95* | Charcot-Marie-Tooth disease type 2 | Pathogenic (Aug 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085003-156085004
- GRCh38:
- Chr1:156115212-156115213
| LMNA | A100fs | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic (Dec 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156085005
- GRCh38:
- Chr1:156115214
| LMNA | R99P | Primary familial dilated cardiomyopathy | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085016
- GRCh38:
- Chr1:156115225
| LMNA | Q103* | not provided | Likely pathogenic (Sep 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085017
- GRCh38:
- Chr1:156115226
| LMNA | Q103R | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr1:156085026
- GRCh38:
- Chr1:156115235
| LMNA | L106P | Charcot-Marie-Tooth disease type 2 | Pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085038
- GRCh38:
- Chr1:156115247
| LMNA | R110fs | not provided | Likely pathogenic (Apr 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085043
- GRCh38:
- Chr1:156115252
| LMNA | E112* | Charcot-Marie-Tooth disease type 2 | Pathogenic (Jan 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085045-156085046
- GRCh38:
- Chr1:156115254-156115255
| LMNA | K114* | not provided | Likely pathogenic (Apr 4, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085056-156085057
- GRCh38:
- Chr1:156115265-156115266
| LMNA | K117fs | Charcot-Marie-Tooth disease type 2, Primary dilated cardiomyopathy | Pathogenic (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156085063-156085064
- GRCh38:
- Chr1:156115272-156115273
| LMNA | R119G | Conduction system disorder | Likely pathogenic (Mar 11, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr1:156085066
- GRCh38:
- Chr1:156115275
| LMNA | | Primary dilated cardiomyopathy, not provided | Pathogenic/Likely pathogenic (Nov 9, 2016) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:156085066
- GRCh38:
- Chr1:156115275
| LMNA | | Charcot-Marie-Tooth disease type 2, not provided | Pathogenic (Aug 28, 2021) | criteria provided, multiple submitters, no conflicts |